Jeannie Visootsak

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials

Elizabeth Berry‐Kravis, Vincent des Portes, Randi J. Hagerman et al. · Science Translational Medicine · 2016 · 264 citations

Life Sciences, Neuroscience, Psychiatry +5

Arbaclofen in fragile X syndrome: results of phase 3 trials

Elizabeth Berry‐Kravis, Randi J. Hagerman, Jeannie Visootsak et al. · Journal of Neurodevelopmental Disorders · 2017 · 184 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +16

A new look at XXYY syndrome: Medical and psychological features

Nicole Tartaglia, Shanlee Davis, Alison Hench et al. · American Journal of Medical Genetics Part A · 2008 · 168 citations · Full text

Life Sciences, Genetics, Pediatrics +14

Independent role for presynaptic FMRP revealed by an <i>FMR1</i> missense mutation associated with intellectual disability and seizures

Leila K. Myrick, Pan‐Yue Deng, Hideharu Hashimoto et al. · Proceedings of the National Academy of Sciences · 2015 · 127 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome

Elizabeth Berry‐Kravis, Joseph P. Horrigan, Nicole Tartaglia et al. · Pediatric Neurology · 2020 · 104 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11